DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis

I. S. Kiselev; Киселев И. С.; O. G. Kulakova; Кулакова О. Г.; O. A. Baturina; Батурина О. А.; M. R. Kabilov; Кабилов М. Р.; A. N. Boyko; Бойко А. Н.; O. O. Favorova; Фаворова О. О.

doi:10.31857/S002689842305004X

DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis

Авторлар: Kiselev I.¹, Kulakova O.¹, Baturina O.², Kabilov M.², Boyko A.¹^,3, Favorova O.¹
Мекемелер:
1. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
2. Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences
3. Federal Center for Brain and Neurotechnology, Federal Medical-Biological Agency
Шығарылым: Том 57, № 5 (2023)
Беттер: 819-826
Бөлім: ГЕНОМИКА. ТРАНСКРИПТОМИКА
URL: https://journals.rcsi.science/0026-8984/article/view/138680
DOI: https://doi.org/10.31857/S002689842305004X
EDN: https://elibrary.ru/GVHYAT
ID: 138680

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Тек жазылушылар үшін

Аннотация
Авторлар туралы
Әдебиет тізімі
Қосымша файлдар
Статистика

Аннотация

Multiple sclerosis (MS) is a chronic autoimmune inflammatory and neurodegenerative disease of the central nervous system, characterized by significant clinical heterogeneity. In 10–15% of patients, primary progressive MS (PPMS) develops, in which, unlike the most common relapsing-remitting form of MS, neurodegeneration steadily progresses and, as a consequence, neurological symptoms continuously increase. Peculiarities of epigenetic regulation of gene expression may be one of the reasons for the differences in the pathogenesis of two MS forms. DNA methylation is one of the key epigenetic mechanisms that remains almost unexplored in different cell populations of PPMS patients. The aim of this work was to identify differential methylation profiles of CpG sites in the CD14+ monocyte DNA that characterize PPMS. Genome-wide analysis of DNA methylation in PRMS patients and healthy individuals identified 169 differentially methylated positions (DMPs), 90.5% of which were hypermethylated in PRMS patients. More than half of all DMPs are located in/near known genes and within CpG islands and their neighboring regions, which indicates their high functional significance. We found six differentially methylated regions (DMRs) in genes OR2L13, CAT, LCLAT1, HOXA5, RNF39, and CRTAC1 involved in inflammation and neurodegeneration, which indicates active epigenetic regulation of their expression.

Негізгі сөздер

Кеуwords: primary progressive multiple sclerosis, inflammation, neurodegeneration, DNA methylation, epigenetic regulation

Әдебиет тізімі

Filippi M., Bar-Or A., Piehl F., Preziosa P., Solari A., Vukusic S., Rocca M.A. (2018) Multiple sclerosis. Nat. Rev. Dis. Primers. 4, 43.
Dendrou C.A., Fugger L., Friese M.A. (2015) Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 15, 545–558.
Olsson T., Barcellos L.F., Alfredsson L. (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat. Rev. Neurol. 13, 25–36.
Waubant E., Lucas R., Mowry E., Graves J., Olsson T., Alfredsson L., Langer-Gould A. (2019) Environmental and genetic risk factors for MS: an integrated review. Ann. Clin. Transl. Neurol. 6, 1905–1922.
Giallongo S., Longhitano L., Denaro S., D’Aprile S., Torrisi F., La Spina E., Giallongo C., Mannino G., Lo Furno D., Zappalà A., Giuffrida R., Parenti R., Li Volti G., Tibullo D., Vicario N. (2022) The role of epigenetics in neuroinflammatory-driven diseases. Int. J. Mol. Sci. 23, 15218.
Koch M., Kingwell E., Rieckmann P., Tremlett H. (2009) The natural history of primary progressive multiple sclerosis. Neurology. 73, 1996–2002.
Correale J., Gaitán M.I., Ysrraelit M.C., Fiol M.P. (2017) Progressive multiple sclerosis: from pathogenic mechanisms to treatment. Brain. 140, 527–546.
Huynh J.L., Garg P., Thin T.H., Yoo S., Dutta R., Trapp B.D., Haroutunian V., Zhu J., Donovan M.J., Sharp A.J., Casaccia P. (2014) Epigenome-wide differences in pathology-free regions of multiple sclerosis-affected brains. Nat. Neurosci. 17, 121–130.
Maltby V.E., Lea R.A., Sanders K.A., White N., Benton M.C., Scott R.J., Lechner-Scott J. (2017) Differential methylation at MHC in CD4+ T cells is associated with multiple sclerosis independently of HLA-DRB1. Clin. Epigenetics. 9, 71.
Maltby V.E., Graves M.C., Lea R.A., Benton M.C., Sanders K.A., Tajouri L., Scott R.J., Lechner-Scott J. (2015) Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients. Clin. Epigenetics. 7, 118.
Кулакова О.Г., Кабилов М.Р., Данилова Л.В., Попова Е.В., Батурина О.А., Царева Е.Ю., Баулина Н.М., Киселев И.С., Бойко А.Н., Фаворов А.В., Фаворова О.О., Власов В.В. (2016) Полногеномный анализ метилирования ДНК мононуклеарных клеток крови больных различными формами рассеянного склероза. Acta Naturae. 8, 39–47.
Киселев И.С., Кулакова О.Г., Данилова Л.В., Батурина О.А., Кабилов М.Р., Попова Е.В., Бойко А.Н., Фаворова О.О. (2022) Полногеномный анализ метилирования ДНК CD4+ T-лимфоцитов больных первично-прогрессирующим рассеянным склерозом свидетельствует о вовлеченности этого эпигенетического процесса в иммунопатогенез заболевания. Молекуляр. биология. 56, 468–475.
Ashhurst T.M., van Vreden C., Niewold P., King N.J.C. (2014) The plasticity of inflammatory monocyte responses to the inflamed central nervous system. Cell. Immunol. 291, 49–57.
Thompson A.J., Banwell B.L., Barkhof F., Carroll W.M., Coetzee T., Comi G., Correale J., Fazekas F., Filippi M., Freedman M.S., Fujihara K., Galetta S.L., Hartung H.P., Kappos L., Lublin F.D., Marrie R.A., Miller A.E., Miller D.H., Montalban X., Mowry E.M., Sorensen P.S., Tintoré M., Traboulsee A.L., Trojano M., Uitdehaag B.M.J., Vukusic S., Waubant E., Weinshenker B.G., Reingold S.C., Cohen J.A. (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162–173.
Tian Y., Morris T.J., Webster A.P., Yang Z., Beck S., Feber A., Teschendorff A.E. (2017) ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 33, 3982–3984.
Teschendorff A.E., Marabita F., Lechner M., Bartlett T., Tegner J., Gomez-Cabrero D., Beck S. (2013) A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 29, 189–196.
Jaffe A.E., Murakami P., Lee H., Leek J.T., Fallin M.D., Feinberg A.P., Irizarry R.A. (2012) Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int. J. Epidemiol. 41, 200–209.
Kiselev I., Danilova L., Baulina N., Baturina O., Kabilov M., Boyko A., Kulakova O., Favorova O. (2022) Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients. Mult. Scler. Relat. Disord. 60, 103714.
Philibert R.A., Terry N., Erwin C., Philibert W.J., Beach S.R., Brody G.H. (2014) Methylation array data can simultaneously identify individuals and convey protected health information: an unrecognized ethical concern. Clin. Epigenetics. 6, 28.
de Mendoza A., Nguyen T.V., Ford E., Poppe D., Buckberry S., Pflueger J., Grimmer M.R., Stolzenburg S., Bogdanovic O., Oshlack A., Farnham P.J., Blancafort P., Lister R. (2022) Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stability. Genome Biol. 23, 163.
Ibitoye R., Kemp K., Rice C., Hares K., Scolding N., Wilkins A. (2016) Oxidative stress-related biomarkers in multiple sclerosis: a review. Biomark. Med. 10, 889–902.
Guy J., Qi X., Hauswirth W.W. (1998) Adeno-associated viral-mediated catalase expression suppresses optic neuritis in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA. 95, 13847–13852.
Fan F., Mo H., Zhang H., Dai Z., Wang Z., Qu C., Liu F., Zhang L., Luo P., Zhang J., Liu Z., Cheng Q., Ding F. (2022) HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target. Biomed. Pharmacother. 155, 113800.
Jia X., Zhao C., Zhao W. (2021) Emerging roles of MHC class I region-encoded E3 ubiquitin ligases in innate immunity. Front. Immunol. 12, 687102.
Kurata R., Nakaoka H., Tajima A., Hosomichi K., Shiina T., Meguro A., Mizuki N., Ohono S., Inoue I., Inoko H. (2010) TRIM39 and RNF39 are associated with Behçet’s disease independently of HLA-B*51 and ‑A*26. Biochem. Biophys. Res. Commun. 401, 533–537.
Renauer P., Coit P., Jeffries M.A., Merrill J.T., McCune W.J., Maksimowicz-McKinnon K., Sawalha A.H. (2015) DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus. Lupus Sci. Med. 2, e000101.
Morin A., Laviolette M., Pastinen T., Boulet L.-P., Laprise C. (2017) Combining omics data to identify genes associated with allergic rhinitis. Clin. Epigenetics. 9, 3.
Campagna M.P., Xavier A., Lea R.A., Stankovich J., Maltby V.E., Butzkueven H., Lechner-Scott J., Scott R.J., Jokubaitis V.G. (2022) Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity. Clin. Epigenetics. 14, 194.
Ewing E., Kular L., Fernandes S.J., Karathanasis N., Lagani V., Ruhrmann S., Tsamardinos I., Tegner J., Piehl F., Gomez-Cabrero D., Jagodic M. (2019) Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during multiple sclerosis progression. EBioMedicine. 43, 411–423.